Effects of bronchoconstriction, minute ventilation, and deep inspiration on the composition of exhaled breath condensate

Chest

Volumn 139, Issue 1, 2011, Pages 16-22

  Debley, Jason S ^a   Ohanian, Arpy S ^a   Spiekerman, Charles F ^b   Aitken, Moira L ^b   Hallstrand, Teal S ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHACHOLINE; PEPTIDOLEUKOTRIENE;

ADULT; AIRWAY; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; EXHALED BREATH CONDENSATE; EXPIRED AIR; FEMALE; FORCED EXPIRATION; FORCED EXPIRATORY VOLUME; HUMAN; INSPIRATORY CAPACITY; LUNG VENTILATION; MALE; PRIORITY JOURNAL;

EID: 78651450298     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-0101     Document Type: Article

References (32)

1. Baraldi E, Carraro S, Alinovi R, et al. Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax. 2003;58(6):505-509. (Pubitemid 36714012)
2. Csoma Z, Kharitonov SA, Balint B, Bush A, Wilson NM, Barnes PJ. Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med. 2002;166(10):1345-1349. (Pubitemid 35292700)
3. Zanconato S, Carraro S, Corradi M, et al. Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma. J Allergy Clin Immunol. 2004;113(2):257-263.
4. Samitas K, Chorianopoulos D, Vittorakis S, et al. Exhaled cysteinyl-leukotrienes and 8-isoprostane in patients with asthma and their relation to clinical severity. Respir Med. 2009;103(5):750-756.
5. Rosias PP, Robroeks CM, Kester A, et al. Biomarker reproducibility in exhaled breath condensate collected with different condensers. Eur Respir J. 2008;31(5):934-942.
6. Chow S, Yates DH, Thomas PS. Reproducibility of exhaled breath condensate markers. Eur Respir J. 2008;32(4):1124-1126.
7. Borrill ZL, Starkey RC, Singh SD. Variability of exhaled breath condensate leukotriene B4 and 8-isoprostane in COPD patients. Int J Chron Obstruct Pulmon Dis. 2007;2(1):71-76. (Pubitemid 46915830)
8. Bloemen K, Lissens G, Desager K, Schoeters G. Determinants of variability of protein content, volume and pH of exhaled breath condensate. Respir Med. 2007;101(6):1331-1337. (Pubitemid 46667659)
9. Leung TF, Li CY, Yung E, Liu EK, Lam CW, Wong GW. Clinical and technical factors affecting pH and other biomarkers in exhaled breath condensate. Pediatr Pulmonol. 2006;41(1):87-94. (Pubitemid 43117373)
10. Debley JS, Hallstrand TS, Monge T, Ohanian A, Redding GJ, Zimmerman J. Methods to improve measurement of cysteinyl leukotrienes in exhaled breath condensate from subjects with asthma and healthy controls. J Allergy Clin Immunol. 2007;120(5):1216-1217. (Pubitemid 350029887)
11. Czebe K, Barta I, Antus B, Valyon M, Horváth I, Kullmann T. Influence of condensing equipment and temperature on exhaled breath condensate pH, total protein and leukotriene concentrations. Respir Med. 2008;102(5):720-725.
12. Liu J, Thomas PS. Relationship between exhaled breath condensate volume and measurements of lung volumes. Respiration. 2007;74(2):142-145.
13. McCafferty JB, Bradshaw TA, Tate S, Greening AP, Innes JA. Effects of breathing pattern and inspired air conditions on breath condensate volume, pH, nitrite, and protein concentrations. Thorax. 2004;59(8):694-698.
14. Kostikas K, Koutsokera A, Papiris S, Gourgoulianis KI, Loukides S. Exhaled breath condensate in patients with asthma: implications for application in clinical practice. Clin Exp Allergy. 2008;38(4):557-565.
15. Horváth I, Hunt J, Barnes PJ, et al; ATS/ERS Task Force on Exhaled Breath Condensate. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J. 2005;26(3):523-548.
16. Effros RM, Hoagland KW, Bosbous M, et al. Dilution of respiratory solutes in exhaled condensates. Am J Respir Crit Care Med. 2002;165(5):663-669.
17. Effros RM, Biller J, Foss B, et al. A simple method for estimating respiratory solute dilution in exhaled breath condensates. Am J Respir Crit Care Med. 2003;168(12):1500-1505.
18. Esther CR Jr, Boysen G, Olsen BM, et al. Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis. Am J Physiol Lung Cell Mol Physiol. 2009;296(6):L987-L993.
19. Baker EH, Clark N, Brennan AL, et al. Hyperglycemia and cystic fibrosis alter respiratory fluid glucose concentrations estimated by breath condensate analysis. J Appl Physiol. 2007;102(5):1969-1975.
20. Dwyer TM. Sampling airway surface liquid: non-volatiles in the exhaled breath condensate. Lung. 2004;182(4):241-250. (Pubitemid 39315286)
21. Zacharasiewicz A, Wilson N, Lex C, et al. Repeatability of sodium and chloride in exhaled breath condensates. Pediatr Pulmonol. 2004;37(3):273-275.
22. Debley JS, Ohanian A, Aitken ML, et al. Airway effects on exhaled breath condensate (EBC) composition [abstract]. Am J Respir Crit Care Med. 2007;175:A318.
23. Miller MR, Hankinson J, Brusasco V, et al; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-338.
24. Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000;161(1):309-329.
25. Tarran R. Regulation of airway surface liquid volume and mucus transport by active ion transport. Proc Am Thorac Soc. 2004;1(1):42-46.
26. Effros RM. Saving the breath condensate approach. Am J Respir Crit Care Med. 2003;168(9):1129-1132.
27. Fairchild CI, Stampfer JF. Particle concentration in exhaled breath. Am Ind Hyg Assoc J. 1987;48(11):948-949.
28. Papineni RS, Rosenthal FS. The size distribution of droplets in the exhaled breath of healthy human subjects. J Aerosol Med. 1997;10(2):105-116. (Pubitemid 27265875)
29. Hunt J. Exhaled breath condensate: an evolving tool for non-invasive evaluation of lung disease. J Allergy Clin Immunol. 2002;110(1):28-34. (Pubitemid 36132721)
30. Noble DD, McCafferty JB, Greening AP, Innes JA. Respiratory heat and moisture loss is associated with eosinophilic inflammation in asthma. Eur Respir J. 2007;29(4):676-681.
31. Scichilone N, Permutt S, Togias A. The lack of the bronchoprotective and not the bronchodilatory ability of deep inspiration is associated with airway hyperresponsiveness. Am J Respir Crit Care Med. 2001;163(2):413-419. (Pubitemid 32158521)
32. Kraft M, Bettinger CM, Wenzel SE, Irvin CG, Ackerman SJ, Martin RJ. Methacholine challenge does not affect bronchoalveolar fluid cell number and many indices of cell function in asthma. Eur Respir J. 1995;8(11):1966-1971.